Got­tlieb re­buts Sci­ence re­port on plum­met­ing FDA in­spec­tions; Lib­tayo wins EMA and NICE en­dorse­ment

→ The jour­nal Sci­ence on Tues­day pub­lished a re­port that con­clud­ed the FDA’s com­pli­ance and en­force­ment ac­tions have plum­met­ed since Don­ald Trump took of­fice, us­ing da­ta com­piled from the agency’s own pub­lic records.

In re­sponse, Scott Got­tlieb — who re­cent­ly ex­it­ed the agency as Trump’s first FDA com­mis­sion­er — de­fend­ed his record. “We were pret­ty ag­gres­sive,” he wrote to Sci­ence. “I don’t think you can paint us with a po­lit­i­cal nar­ra­tive—that just be­cause we were a Re­pub­li­can ad­min­is­tra­tion, some­how we must have ratch­eted down en­force­ment ac­tiv­i­ty. We didn’t.” Got­tlieb, much like the ma­jor­i­ty of for­mer FDA com­mis­sion­ers that pre­ced­ed him, has joined the in­dus­try he once reg­u­lat­ed. Last week, he ac­cept­ed a po­si­tion on Pfiz­er‘s $PFE board of di­rec­tors, spark­ing a storm of crit­i­cism af­ter tak­ing the fastest route be­tween com­mis­sion­er and big phar­ma seen in the agency’s his­to­ry.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.